Mp62-13 Long-Term Medication Use After Surgical Treatment for Bladder Outlet Obstruction, How Does Holep Compare to Other Surgical Modalities?

You have accessJournal of UrologyBenign Prostatic Hyperplasia: Surgical Therapy holmium laser ablation of prostate (HoLAP), transurethral resection of prostate (TURP), and simple prostatectomy (SP), and office procedures; transurethral microwave thermotherapy (TUMT), transurethral needle ablation (TUNA), water vaporization (Rezum), and prostatic urethral lift (PUL). Multivariable Cox hazard models (p90 days) medication. Cumulative incidence of restarting medication within 1 year of surgery was 45.5%, 32.5%, and 22.7% for office, hospital, and HoLEP (Figure 1). CONCLUSIONS: Resumption of medication is common after BOO procedures. When compared to other modalities, HoLEP is significantly less likely to require medical retreatment. As office procedures become more common, it is important to counsel patients that more than 40% will restart BPH medication within 1 year after surgery. Download PPT Source of Funding: None © 2024 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 211Issue 5SMay 2024Page: e1026 Advertisement Copyright & Permissions© 2024 by American Urological Association Education and Research, Inc.Metrics Author Information Talia A. Helman More articles by this author Dattatraya Patil More articles by this author Siddarth Marthi More articles by this author Brendan Browne More articles by this author Expand All Advertisement PDF downloadLoading ...